Condition
Varicosis
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Clarivein
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Clarivein1
- Triple Cream1
- Qs Ndyag Laser1
Active Sponsors
- Rijnstate Hospital1
- St. Antonius Hospital1
- Insel Gruppe AG, University Hospital Bern1
Top Investigators
Insel Gruppe AG, University Hospital Bern
St. Antonius Hospital
Rijnstate Hospital
Related Conditions
- Hyperpigmentation1